Abstract:Nucleic acids contain a variety of different base modifications, such as decoration at the fifth position of cytosine, which is one of the most important epigenetic modifications. Nucleic acid epigenetics mediate a wide variety of biological processes, including embryonic development and gene regulation, genomic imprinting, differentiation, and X-chromosome inactivation. Furthermore, the modification level can be aberrantly expressed in distinct sets of tissue that can indicate different tumor onsets and canceration. Thus, the analysis of modified nucleobases may contribute to the understanding of epigenetic modification-related biological processes and the correlation of modified nucleobase patterns with disease states for clinical diagnosis and treatment. In addition to 5-methylcytosine, 5-hydroxymethylcytosine, 5-formylcytosine, and 5-carboxycytosine are found in organisms at a low content but are nevertheless extremely important chemical modifications, and 5-hydroxyuracil and 5-formyluracil compounds are also present. 5-Formyluracil is found in bacteriophages, prokaryotes, and mammalian cells. The 5-formyluracil content is higher in certain cancer tissues than in the normal tissues adjacent to the tumor. The content of 5-formyluracil in different cell tissues may have cell type specificity. With the continuous use of chemical tools, new detection technologies have greatly advanced the research on natural pyrimidine modifications. These modifications dynamically regulate the gene expression in eukaryotes and prokaryotes and provide mechanistic insights into the occurrence of diseases. Natural pyrimidine modifications act not only as intermediates for DNA demethylation or oxidative damage products but also as modulators of gene expression. Therefore, the development of more effective chemical tools will help us better understand the dynamic changes of natural pyrimidine modifications in vivo. In this Account, we summarize the recent advanced techniques for the detection of 5-formylpyrimidine (5-formylcytosine and 5-formyluracil) and highlight their great potential as biomarkers in biomedical applications. Focusing on the great urgency for the detection of epigenetic modifications, our group developed a series of methods for the qualitative and quantitative analysis of 5-formylpyrimidine in the past few years, aiming at facilitating the accurate detection and mapping of these epigenetic modifications. By the construction of probes, 5-formylpyrimidine can be selectively labeled. Using mass spectrometry, the epigenetic modifications can be quantified. Upon treatment under specific conditions, 5-formylcytosine can be recognized at single-base resolution. With this Account, we anticipate providing chemical and biological researchers with some insight to unlock the complex mechanism involved in 5-formylpyrimidine-related biological processes and stimulate more collaborative research interests from the different fields of materials, biological, medicine, and chemistry to promote the translational research of epigenetics in tumor diagnosis and treatment.

Determination of Formylated DNA and RNA by Chemical Labeling Combined with Mass Spectrometry Analysis

Precise Identification of an RNA Methyltransferase's Substrate Modification Site

Preparation of Human Nuclear RNA m⁶A Methyltransferases and Demethylases and Biochemical Characterization of Their Catalytic Activity.

Detection and Application of 5-Formylcytosine and 5-Formyluracil in DNA

Highly Selective Electrochemical Detection of 5-Formyluracil Relying on (2-Benzimidazolyl) Acetonitrile Labeling

Ultrasensitive determination of rare modified cytosines based on novel hydrazine labelling reagents.

Identification and quantification of N 6 -methyladenosine by chemical derivatization coupled with 19 F NMR spectroscopy

A chemical labeling of N6-formyl adenosine (f6A) RNA

Mass-Spectrometry-Based Assay at Single-Base Resolution for Simultaneously Detecting M6a and M6am in RNA

Determination of dimethylated nucleosides in serum from colorectal cancer patients by hydrophilic interaction liquid chromatography-tandem mass spectrometry

DNAzyme based three-way junction assay for antibody-free detection of locus-specific N6-methyladenosine modifications

Mass Spectrometry-Based Method to Measure Aflatoxin B 1 DNA Adducts in Formalin-Fixed Paraffin-Embedded Tissues

Methylation-Powered Assembly of a Single Quantum Dot-Based FRET Nanosensor for Antibody-Free and Enzyme-Free Monitoring of Locus-Specific N 6 -Methyladenosine in Clinical Tissues

Detection and Quantification of 5moU RNA Modification from Direct RNA Sequencing Data

A Novel Malic Acid-Enhanced Method for the Analysis of 5-Methyl-2′-deoxycytidine, 5-Hydroxymethyl-2′-deoxycytidine, 5-Methylcytidine and 5-Hydroxymethylcytidine in Human Urine Using Hydrophilic Interaction Liquid Chromatography-Tandem Mass Spectrometry

Identification and Quantification of 5-Methylcytosine and 5-Hydroxymethylcytosine on Random DNA Sequences by a Nanoconfined Electrochemiluminescence Platform

Incorporation And/or Adduction of Formic Acid with DNA in Vivo Studied by HPLC–AMS

Mass Spectrometry-Based Targeted Serum Monomethylated Ribonucleosides Profiling For Early Detection Of Breast Cancer

Recent Advance in the Study on 5‐Formylcytosine (f5C) RNA Modification

Sequencing-free Analysis of Multiple Methylations on Gene-Specific mRNAs

A novel method to purify small RNAs from human tissues for methylation analysis by LC-MS/MS